Population
Human apolipoprotein B metabolism
Comparison
Presence of apolipoprotein C-III on lipoproteins vs Absence of apolipoprotein C-III on lipoproteins
Authors
Loading...
Strengthens rationale for ApoCIII-targeted therapies in dyslipidemia; leaves open effects on clinical cardiovascular outcomes.
ApoCIII strongly inhibits the hepatic uptake of VLDL and IDL and enhances the conversion of light LDL to dense LDL, highlighting its atherogenic role in lipid metabolism.
Mendivil et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: